Overview Ketorolac vs. Steroid in the Prevention of CME Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Evaluate if the incidence of sub clinical CME can be significantly reduced by use of peri-operative Acular LS plus Pred Forte when compared with Pred Forte alone in normal cataract patients. Phase: Phase 4 Details Lead Sponsor: Innovative MedicalTreatments: KetorolacKetorolac TromethamineMethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate